Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04243525
Other study ID # STUDY19060285
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 2009
Est. completion date May 2030

Study information

Verified date September 2023
Source University of Pittsburgh
Contact Claudia Ramos Rivers, MD
Email cmr95@pitt.edu
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Patients seen at the Center for Inflammatory Bowel Disease will be asked to provide their written informed consent (authorization) to allow their identifiable medical record information related to their Inflammatory Bowel Disease to be placed in Center's Research Registry for the purpose of facilitating retrospective research studies directed at Inflammatory Bowel Disease, and the identification and recruitment of potential, eligible subjects for participation in future research studies involving Inflammatory Bowel Disease. Information obtained from the Inflammatory Bowel Disease Registry will allow a better classification of disease and factors that influence the natural course of disease; which may lead to a better understanding of the pathogenesis of IBD and may permit the development of better therapies and the potential for preventive therapies.


Recruitment information / eligibility

Status Recruiting
Enrollment 5000
Est. completion date May 2030
Est. primary completion date May 2030
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: All patients age 18 and above seeking medical care at the Center for Inflammatory Bowel Diseases Clinic at UPMC Exclusion Criteria: N/A

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States University of Pittsburgh Medical Center Pittsburgh Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
University of Pittsburgh

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients with IBD 20 years